Our Team
Srinivas Akkaraju, M.D., Ph.D.
Managing Director
Dr. Akkaraju is a co-founder of Panorama and focuses primarily on life sciences investments. He joined JPMorgan Partners in 2001. From 1998 to 2001, Dr. Akkaraju was in Business and Corporate Development at Genentech, Inc., most recently as Senior Manager responsible for worldwide partnering activities, in-licensing of therapeutics, and out-licensing of development projects. In addition to his business development role, Dr. Akkaraju also served as a Project Team Leader for one of Genentech’s clinical development products. During this time, he also was a founding member of BioStreet, an online marketplace for biotech opportunities.
Dr. Akkaraju holds B.A. degrees in both Biochemistry and Computer Science from Rice University and an M.D. and Ph.D. in Immunology from Stanford University School of Medicine. Dr. Akkaraju currently serves on the board of directors of Barrier Therapeutics, Inc. (NASDAQ:BTRX), Phenomix Corporation, Piramed Limited, Seattle Genetics, Inc. (NASDAQ:SGEN), and Pharmos, Inc (NASDAQ:PARS).